Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
osteoporosis drug
Pharma
Repatha helps Amgen overcome Prolia's LOE freefall in Q1
Sales of Amgen's Repatha were up 34% in Q1 to $876M and helped the company overcome the freefall of Prolia, which now faces biosimilar competition.
Kevin Dunleavy
May 1, 2026 8:18am
2 investment firms buy Radius, bone drug Tymlos for $890M
Jun 23, 2022 11:30am
Entera moves oral rival to Lilly's Forteo toward pivotal trial
Oct 11, 2021 7:30am
Amgen prices bone drug Evenity on par with rival Tymlos
Apr 16, 2019 12:18pm
Amgen bone drug Evenity wins FDA nod, but with strings attached
Apr 10, 2019 10:38am
Can Amgen's Evenity rebound? FDA, analysts aren't so sure
Jan 14, 2019 12:20pm
